[{"Assets_0_Q3_USD":89629000.0,"CommonStockSharesOutstanding_0_Q3_shares":57988702.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-27175000.0,"NetIncomeLoss_1_Q3_USD":-14809000.0,"NetIncomeLoss_3_Q3_USD":-30166000.0,"StockholdersEquity_0_Q3_USD":57116000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":723000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":11813000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]